ArticleEuropean journal of medical research2025
Effect of day 3 cell number on the pregnancy and neonatal outcomes of vitrified-warmed single blastocyst transfer.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Late-stage vacuolization as a compaction-dependent prognostic marker for day 4 embryo selection.Reproduction & fertility · 2026Article
- Development and validation of a predictive model for early blastocyst formation on day 4 post-fertilization.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe aim of this retrospective cohort study was to evaluate the effect of day 3 embryo cell number on the clinical pregnancy and neonatal outcomes of single blastocyst transfer in frozen embryo transfer (FET) cycles.
methodsThe study included 1220 single blastocyst transfer from FET cycles conducted between January 2017 and April 2024. Patients were categorized into four groups based on day 3 embryo cell number : 110 cycles in the < 7-cell group, 743 cycles in the 7-9-cell group, 282 cycles in the 10-13-cell group, and 84 cycles in the > 13-cell group. The study compared the clinical pregnancy outcomes and neonatal outcomes among the four groups.
resultsWhen the maternal age was < 35 years or high-quality blastocysts were transferred, the clinical pregnancy rate (CPR) of the < 7-cell group was significantly lower than those of other three groups (all P < 0.008). Similarly, when high-quality blastocysts were transferred, the live birth rates (LBRs) of the 7-9-cell group and > 13-cell group were significantly higher than those of the < 7-cell group (all P < 0.008). In women aged < 35 years with high-quality blastocyst transfers, after adjusting for confounders, 7-9 and 10-13 groups were with significantly higher CPR (aOR 2.66, 95% CI 1.44-4.91; aOR 2.15, 95%CI 1.10-4.18 and LBR (aOR 2.50, 95%CI 1.32-4.73, aOR 1.74, 95% CI 0.88-3.46).
conclusionIn FET cycles, a low day 3 cell number (< 7-cell) on day 3 was related to decreased CPR and LBR after blastocyst transfer, whereas a number > 9 was comparable to that of 7-9 cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.